How does HTLV-I persist despite a strong cell-mediated immune response?

被引：46

作者：

Asquith, Becca ^{[1
]}

Bangharn, Charles R. M. ^{[1
]}

机构：

[1] Univ London Imperial Coll Sci Technol & Med, Dept Immunol, Wright Fleming Inst, London W2 1PG, England

来源：

TRENDS IN IMMUNOLOGY | 2008年 / 29卷 / 01期

基金：

英国医学研究理事会;

关键词：

D O I：

10.1016/j.it.2007.09.006

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Human T-lymphotropic virus type 1 (HTLV-1) is a pathogenic retrovirus that infects human CD4(+) T lymphocytes. Despite its presence in T cells, HTLV-1 causes little overt immunosuppression. This host-virus relationship has therefore been exploited as an excellent model system for studying the dynamic interaction between a persistent retrovirus and the normal human immune system. We use a combination of mathematical and experimental techniques to identify key factors on both sides of the in vivo host-virus interaction that significantly determine HTLV-1 proviral load and disease risk. We develop a model to describe how these factors interact to enable viral persistence.

引用

收藏

页码：4 / 11

页数：8

相关论文

共 61 条

[1] Inefficient cytotoxic T lymphocyte-mediated killing of HIV-1-infected cells in vivo [J].

Asquith, B ;

Edwards, CTT ;

Lipsitch, M ;

McLean, AR .

PLOS BIOLOGY, 2006, 4 (04) :583-592

[2] An introduction to lymphocyte and viral dynamics: the power and limitations of mathematical analysis [J].

Asquith, B ;

Bangham, CRM .

PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2003, 270 (1525) :1651-1657

[3] A functional CD8+ cell assay reveals individual variation in CD8+ cell antiviral efficacy and explains differences in human T-lymphotropic virus type 1 proviral load [J].

Asquith, B ;

Mosley, AJ ;

Barfield, A ;

Marshall, SEF ;

Heaps, A ;

Goon, P ;

Hanon, E ;

Tanaka, Y ;

Taylor, GP ;

Bangham, CRM .

JOURNAL OF GENERAL VIROLOGY, 2005, 86 :1515-1523

[4] Quantification of the virus-host interaction in human T lymphotropic virus I infection [J].

Asquith, B ;

Mosley, AJ ;

Heaps, A ;

Tanaka, Y ;

Taylor, GP ;

McLean, AR ;

Bangham, CRM .

RETROVIROLOGY, 2005, 2 (1)

[5] Quantifying HTLV-I dynamics [J].

Asquith, Becca ;

Bangham, Charles R. M. .

IMMUNOLOGY AND CELL BIOLOGY, 2007, 85 (04) :280-286

[6] In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection [J].

Asquith, Becca ;

Zhang, Yan ;

Mosley, Angelina J. ;

de lara, Catherine M. ;

Wallace, Diana L. ;

Worth, Andrew ;

Kaftantzi, Lambrini ;

Meekings, Kiran ;

Griffin, George E. ;

Tanakall, Yuetsu ;

Toughfi, David F. ;

Beverley, Peter C. ;

Taylorl, Graham P. ;

Macallant, Derek C. ;

Bangham, Charles R. M. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (19) :8035-8040

[7] Cellular immune response to HTLV-1 [J].

Bangham, CRM ;

Osame, M .

ONCOGENE, 2005, 24 (39) :6035-6046

[8] Analysis of total human immunodeficiency virus (HIV)-specific CD4+ and CD8+ T-cell responses:: Relationship to viral load in untreated HIV infection [J].

Betts, MR ;

Ambrozak, DR ;

Douek, DC ;

Bonhoeffer, S ;

Brenchley, JM ;

Casazza, JP ;

Koup, RA ;

Picker, LJ .

JOURNAL OF VIROLOGY, 2001, 75 (24) :11983-11991

[9] HLA and HIV-1:: Heterozygote advantage and B*35-Cw*04 disadvantage [J].

Carrington, M ;

Nelson, GW ;

Martin, MP ;

Kissner, T ;

Vlahov, D ;

Goedert, JJ ;

Kaslow, R ;

Buchbinder, S ;

Hoots, K ;

O'Brien, SJ .

SCIENCE, 1999, 283 (5408) :1748-1752

[10]

Cavrois M, 1996, ONCOGENE, V12, P2419

← 1 2 3 4 5 6 7 →